Dr. Susan Love and research

While I was writing the post on the robot MRI (see below) I noted that Dr. Susan Love has several research projects within her foundation. I thought I would post on some of these because of their importance.

While the robot MRI might be years in the future these studies are open now to qualifying women. Here is one that is quite intriguing in that a small amount of chemotherapy is injected into the tumor area after diagnosis. Read on and please visit Dr. Love's blog and main page.
http://www.dslrf.org/endingbc/content.asp?L2=1&L3=7&L4=4&SID=292


Effect of Intraductal Therapy of DCIS with Pegylated Liposomal Doxorubicin (PLD) on Pathology and Biomarkers: A Presurgery Study
(Currently Recruiting)
The Dr. Susan Love Research Foundation is looking for 30 women recently diagnosed with ductal carcinoma in situ (DCIS) to take part in a groundbreaking new research project. Study volunteers will need to have been diagnosed with a core needle biopsy or with ultrasound and not yet have had surgery. The study involves having a small amount of a chemotherapy drug injected through the nipple into the affected milk duct. The volunteer will be observed for a couple of hours, and then go home, with a surgery date set in the next four to six weeks. Prior to surgery, ductal fluid will be aspirated and an MRI will be performed. The tissue removed during the surgery will be examined to see what effect the drug had on the DCIS. It is hoped that the findings from study will provide the data necessary to support the launch of a nationwide clinical trial of intraductal therapy for the treatment of DCIS.

This research is being conducted in collaboration with Ellen Mahoney, MD, St. Joseph's Hospital in Eureka, Calif., and the Humboldt Community Breast Health Project. Research participants will need to travel to Eureka, Calif., for the treatment and the surgery. This study was funded by the California Breast Cancer Research Program (CBCRP). Please call Ashley Casano at (310) 828-0060 Ext. 32 or send her an email for more information.